Psychedelic drugs, like psilocybin and MDMA, have captivated global interest for their potential in treating mental health disorders. While Australia has become the first country in the world to permit the prescription of these drugs, their efficacy is unconfirmed and access to these potentially transformative treatments is limited.

Dr Dilara Bahceci is a neuroscientist who specialises in the therapeutic potential of these psychoactive drugs. In this bitesize episode of the Scan, Dilara emphasizes the pressing need to innovate mental health treatments and champions equitable access. Tune in to explore the evolving research landscape and exciting prospects ahead.